Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 01-2022 | 10-2021 | |
| Operating Expenses | 0 | 3,362 |
| Operating Income | N/A | -3,362 |
| Interest Expense | 0 | 15 |
| Other Income | 0 | -3,902 |
| Pre-tax Income | 0 | -7,279 |
| Income Tax | N/A | 32 |
| Net Income Continuous | -1,651 | -7,310 |
| Net Income | $-1,651 | $-7,310 |
| EPS Basic Total Ops | -60.06 | N/A |
| EPS Basic Continuous Ops | -52.75 | N/A |
| EPS Diluted Total Ops | -60.06 | N/A |
| EPS Diluted Continuous Ops | -52.75 | N/A |
| EBITDA(a) | $N/A | $-3,362 |